Literature DB >> 25497962

Clofazimine analogs with antileishmanial and antiplasmodial activity.

Anna Barteselli1, Manolo Casagrande1, Nicoletta Basilico2, Silvia Parapini3, Chiara M Rusconi1, Michele Tonelli4, Vito Boido4, Donatella Taramelli3, Fabio Sparatore4, Anna Sparatore5.   

Abstract

A set of novel riminophenazine derivatives has been synthesized and evaluated for in vitro activity against chloroquine-sensitive (CQ-S) and chloroquine-resistant (CQ-R) strains of Plasmodium falciparum and against different species of Leishmania promastigotes. Most of the new compounds inhibited the growth of Leishmania promastigotes as well as CQ-S and CQ-R strains of P. falciparum with IC50 in submicromolar range, resulting in the best cases 1-2 orders of magnitude more potent than the parent compound clofazimine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antileishmanial activity; Antiplasmodial activity; Clofazimine; Clofazimine analogs; Pyrrolizidinyl-alkyliminophenazine derivatives; Quinolizidinyl-alkyliminophenazine derivatives

Mesh:

Substances:

Year:  2014        PMID: 25497962     DOI: 10.1016/j.bmc.2014.11.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  In vitro investigation of clofazimine analogues for antiplasmodial, cytotoxic and pro-oxidative activities.

Authors:  E M Makgatho; E F Mbajiorgu
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

Review 2.  Repurposing Drugs to Fight Hepatic Malaria Parasites.

Authors:  Diana Fontinha; Isabel Moules; Miguel Prudêncio
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

Review 3.  Recent Advances in the Discovery of Novel Antiprotozoal Agents.

Authors:  Seong-Min Lee; Min-Sun Kim; Faisal Hayat; Dongyun Shin
Journal:  Molecules       Date:  2019-10-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.